Host phagocytes respond to infections by innate defense mechanisms through metabolic 13 shuffling in order to restrict the invading pathogen. However, this very plasticity of the host 14 provides an ideal platform for pathogen mediated manipulation. By employing the macrophage 15 model of Mtb infection, we identify an important strategy employed by modern clinical lineages 16 in regulating the host immune-metabolism axis. The potent ability of these strains to specifically 17 elicit a strong and early macrophage type I IFN response (in contrast to the protracted response 18 to ancient Mtb), was dependent on an increased ability to localize in acidified phagosomes; this 19 higher transit via acidified compartments is important for stimulation of the DNA dependent 20 signaling in infected macrophages. The augmented IFN signaling provided a positive regulatory 21 loop for enhanced expression of the cellular oxysterol-CH25H which in turn facilitated higher 22 levels of IL6 in macrophages infected with the modern Mtb strains. Requirement of type I IFN 23 signaling in mycobacterial intracellular growth highlights another unique ability of Mtb to 24 manipulate host cell physiology and proinflammatory responses. 25
Significance Statement: 29
Co-evolution with humans has enabled the development of novel adaptive mechanisms for 30 survival in host specific environments in the human TB pathogen-Mtb. We present one such 31 mechanism of modern Mtb strains harnessing the type I IFN immune axis to regulate the host 32 pro-inflammatory response. Our results highlight the use of host intracellular endosomal transit 33 as a mechanism by these strains to ensure a strong type I IFN response in macrophages. We 34 also demonstrate the ability of Mtb to regulate macrophage cholesterol metabolism in order to 35 fine tune the host innate responses. These findings lay the foundation of the future development 36 of a host axis directed intervention strategy against this pathogen. 37
Introduction: 38
A long-standing association with the human population has been critical to the 39 development of specific immune modulatory mechanisms by Mycobacterium tuberculosis (Mtb) 40 for efficient survival within the host. With the advent of high throughput genome analysis, Mtb 41 strains have been differentiated into 7 distinct groups that can be classified into phylogenetically 42 ancient (restricted geographic penetration) and modern (widespread) lineages. Analysis of 43 strain specific differences in their virulence and disease manifestation has led to identification of 44 possible molecular correlates of virulence (1-3). 45
The initial contact of Mtb with macrophages activates the cGAS-STING-nucleic acid 46 signaling pathway leading to type I IFN expression (4, 5) . This response is mediated by host 47 factors like ROS induced mitochondrial damage and pathogen associated factors like ESX-1 48 mediated phagosomal escape and mycobacterial cyclic di-nucleotides (6-10). A detrimental 49 pathogenic effect has been associated with Mtb induced type I IFN signaling in regulating the 50 expression of cytokines such as TNFα, IL12 and IL10 in macrophages (11-13). Moreover, type I 51
IFNs have been shown to alter the IFN dependent activation of macrophages and consequent 52 mycobacterial growth (14). However, another study has also suggested a beneficial role for the 53 mycobacteria induced type I IFN signaling in IL12 production and antigen presentation by 54
macrophages (15). 55
Clinical Mtb lineages vary significantly in their inflammatory response induction andimmune modulatory functions (16) (17) (18) . Given the duality of the outcome of type I IFN induction 57 by Mtb in macrophages, mechanisms underlying strain specific type I IFN is still unclear. We 58 demonstrate that the higher type I IFN induction (IFNβ) by modern lineages (L3, L4 and L2) is 59 dependent on bacterial DNA presentation to the cGAS-STING signaling pathway as a result of 60 an early and increased bacterial trafficking via the endo-lysosomal pathway. Consistent with this 61
augmented IFNβ and enhanced expression of the IFN stimulated, immunomodulatory (pro 62 inflammatory) oxysterol-CH25H, significantly higher levels of IL6 were observed in 63 To test if L1 Mtb strains were attenuated in overall macrophage activation, we tested gene 127 expression and cytokine profiles of RAW264.7 macrophages infected with L1 and L3 Mtb. Both 128 TNF and IL6 patterns were strikingly similar to type I IFN, with lower levels in the case of L1 129 than the L3 infected RAW264.7 macrophages after 24 hours ( Fig. 2A) . This attenuated IL6 and 130 TNF expression was also observed in bone marrow-derived macrophages from C57BL/6 mice 131 with L1 Mtb inducing minimal amounts of the cytokines (Fig. 2B ). L3 Mtb induced significantly 132 higher levels of IL6 in a temporal manner attaining peak values by 48h of infection as opposed 133 to minimal levels of cytokines even by 72h of L1 Mtb infection (Fig. 2C) . A similar pattern of low 134 IL6 induction by L1 Mtb in human monocyte derived macrophages of 4 healthy individuals at 6h 135 and 24h of infection suggested a universal mechanism of regulation in the macrophage 136 response pathway by this mycobacterial strain (Fig. 2D) . 137
To check if the regulation was at the transcript level, we compared gene expression by qPCR. 138
In macrophages infected with N24, ~30 fold higher il6 expression was observed than in N73 139 infected cells as early as 6h p.i. While the expression declined at a later time point (24h) in 140 these macrophages, the overall levels were significantly higher than in the N73 infected cells 141 (Fig. 2E) . 142
Both strains were capable of inducing il6 by 6h; N24 by 34 folds and N73 by 7 folds. While we 143 did not observe any change in the levels of il6 expression in the N73 infected STING 144 macrophages, the differential higher response (~5x) seen in the case of N24 infection was lost 145 (Fig. 2F) (Fig. S2) . Most of the genes involved in the cholesterol biosynthetic pathway 153 were either up-regulated or similar in L1 infected macrophages after 24h of infection. In 154 contrast, these genes were inhibited in response to infection with L3 Mtb. Surprisingly, in 155 contrast with the overall pathway, the expression of CH25H was significantly upregulated in the 156 L3 infected macrophages (60-70-fold higher than the uninfected control) as opposed to a much 157 lower expression of this gene (3-4 folds) in the L1 infected macrophages, by 6h of infection (Fig. 158 2G). This difference was, however, lower at 24h, wherein a sharp decline in L3 (23 folds) and 159 an increase in L1 infected macrophages (10-12 folds) was observed. Given the increased 160 CH25H expression and requirement of type I IFN for enhanced IL6 expression, we tested if 161 STING signaling contributed to the early increase of CH25H in L3 Mtb infected macrophages. 162
The complete loss of CH25H expression in STING macrophages substantiates our hypothesis 163 of a regulatory role for type I IFN in host oxysterol mediated IL6 response in modern Mtb 164 infected macrophages (Fig. 2H) . 165 Previous studies have implicated an important role of the Mtb ESX-1 secretion system in 182 cytosolic egress of ligands and activation of the cytosolic surveillance pathway resulting in type I 183 IFN activation (5, 10). However, we did not observe any difference between the IFN inducing 184 abilities of H37Ra or H37Rv despite the reported differences in the levels of the Esx-1 proteins 185 (24). Further, comparable expression of ESAT6 in our clinical Mtb strains (L1 and L3) (Fig. 186 S3A) argued for an esx-1 independent mechanism of Type 1 IFN induction. 187
We also did not observe any difference in mitoSOX staining of macrophages infected with either 188
Mtb strain, contrasting with the previously identified mode of mitochondrial ROS mediated type I 189 IFN signaling (10) hinting at alternative early events associated with recognition of bacterial 190
ligands (Fig. S3B). 191
Having ascertained that N73 did not suppress IFN induction, it was logical to assume lack/ lower 192 quantities of the active ligand as an underlying cause for the deferred IFN response by L1 Mtb. (Fig. 3B) . Surprisingly, 205 genomic DNAs from N73 as well as BCG were similar to Erdman and N24 in their IFN inducing 206 capacities (Fig. 3C ). Given the presence of an active molecule (DNA) even in Mtb strains with 207 attenuated IFN induction, it was reasonable to assume the lack of DNA presentation as the 208 basis for lower IFN. A preliminary evaluation hinted at a temporal IFN response to Mtb Erdmanextract (cell lysates) when delivered to THP1 cells via transfection, with the response increasing 210 from ~10 folds at 3h to ~75 folds by 6h and then declining to ~10-fold expression by 24h of 211 stimulation with different doses (Fig. 3D) . Even though very low amounts of the extract (1.6 ng) 212 was sufficient to induce ten-fold IFN by 6h (Fig. S4B) , the complete loss of IFN only in extracts 213 subjected to DNAse digestion argued for the pivotal role of DNA sensing in Mtb induced type I 214 IFN in macrophages and its inaccessibility to the IFN signaling machinery of macrophages (Fig.  215   3E) . Further proof of effective ligand masking by L1 Mtb and BCG came from our observation 216 that delivery of BCG with lipofectamine was sufficient to enhance the Type I IFN response by 6 217 folds compared to BCG infection without lipofectamine (Fig. 3F) . 218 219 
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Early localization to acidified compartments is important for Mtb induced type I IFN 231 induction 232
The early induction of type I IFN in L3 infected macrophages advocated for molecular events 233 that ensue immediately after infection as causative. Further, analysis of THP1 macrophages by 234 TEM revealed the differential localization of the Mtb clinical isolates in distinct intracellular 235 compartments-N24 localized to compact double membranous vesicles at 24h in contrast to N73 236 that were confined in larger less defined vesicular structures with intracellular particles (Fig. 4A) . 237
In support of this observation, we observed that Mtb N24 localized to lysotracker positive (lyso+) 238 vesicles at significantly higher numbers than N73 at 24h p.i. (Fig. 4B ). This differential 239 localization to lyso+ vesicles between N24 and N73 was also observed in RAW264.7 240 macrophages. In a temporal analysis of Mtb transit via the endosomal pathway, differential 241 localization between Mtb strains arose as early as 1h of infection with more than two-fold N24 in 242 the lyso+ vesicles as compared to N73 (Fig. 4C) . Despite a gradual decrease of N24 in lyso+ 243 positive vesicles with time, consistently 2-fold higher numbers of N24 was seen throughout the 244
We have previously demonstrated that L1 strains harbor a mutation in papA2, rendering them 246 incapable of sulfolipid synthesis (28). A dominant role for the Mtb sulfolipids has also been 247 demonstrated in modulation of the cellular phagosome maturation and acidification (29-31). We 248 questioned whether the lack of sulfolipids renders Mtb incapable of inducing the type I IFN 249 response. To test this hypothesis, we deleted mmpL8, coding for an exporter of mature 250 sulfolipids to the bacterial cell surface and measured induction of the Type I IFN response in the 251 reporter cells. There was no loss of IFN inducing ability of Mtb in the absence of mmpL8 (Fig.  252   S5) , supporting an alternative reason for the differential induction of the type I IFN response. 253
Another finding supporting the lack of sulfolipid not to be responsible for this phenotype is the 254 inability of the Vietnamese strain of L1 lineage to induce significant Type I IFN response despite 255 expressing sulfolipids in the membrane (Fig. 1B) . 256 257 (Fig. 5A) . 275
Importantly, the numbers of lyso+ N73 Mtb increased to comparable levels as N24 Mtb by 6h of 276 infection (Fig. 5B) . Consequently, a 10-fold higher type I IFN response was observed in N73 277 infected IFN+ LPS pretreated macrophages leading to loss of the differential IFN response 278 between strains (Fig. 5C and inset panel) . While, addition of IFN and LPS significantly boosted 279 type I IFN induction even in N24 infected macrophages, treatment with phagosome acidification 280 blockers like bafilomycin A or chloroquine on the contrary, stunted (~5 and 2 folds, respectively) 281 the IFN response in these cells (Fig. 5D ) emphasizing the importance of phagosomal trafficking 282 and acidification in Mtb mediated IFN induction in macrophages. 283
Abrogation of DNA signaling arrests mycobacterial growth in macrophages 285
In an effort to test the physiological relevance of type I IFN, we analyzed the ability of Mtb N24 286 to grow in Wt ISG and macrophages deficient in STING or TRIF. Over 3 days of culture, Wt 287 macrophages supported Mtb growth (Fig. 6) . In contrast, despite, similar levels of uptake in the 288 deficient macrophages, Mtb N24 growth was restricted to initial levels at all times 289 (Fig. 6) . 305 While sulfolipids have been demonstrated in promoting phagosomal acidification and L1 strains 360 lack sulfolipids, our results do not purport an active role for this lipid in the type I IFN response. 361
Despite the presence of mature sulfolipids in the L1 subtype Mtb strains T83 (28), induction oftype I IFN was relatively low in THP1 macrophages. Moreover, while differences in sulfolipid 363 expression between H37Ra and H37Rv is well established (47, 48), there was no discernable 364 alteration of IFN expression between the two Mtb strains. The complete lack of change in IFN 365 induction ability of a sulfolipid deficient Erdman Mtb (M8) further absolves the critical role of 366 sulfolipid in type I IFN induction by Mtb (Fig. S5) . 367
In summary, we identify a novel means for modern strains of Mtb to mount a pathogenic 368 immune response via their early passage through an acidified endosomal compartment. This 369 passage allows presentation of their DNA to cytosolic sensors, which then triggers a cholesterol 370 driven feed forward loop of pro-inflammatory responses. An understanding of these early 371 trafficking events in the future will help identify means to counter this pathogenic immune 372 response triggered by the modern Mtb strains. 373
Material and Methods 374
Bacterial Strains and Growth Conditions-Mycobacterial and E. coli strains were cultured as 375 per standard protocols with the appropriate supplements and selection antibiotics as required. 376
The M6 promoter fragment was amplified as described earlier (49) and cloned upstream of GFP 377 in the mycobacterial expression vector-pMV261 and electroplated into mycobacteria. 378
Expression of ESAT6 in the culture filtrate and secreted Mtb cultures was performed by 379 immunoblotting with anti ESAT6 monoclonal antibody HYB76-8 as described earlier (3). The 380 mmpL8 null mutant (ΔM8) was created by homologous recombination using specialized 381 transduction and recombineering as described earlier (50). Transducing phages generate by 382 recombineering mediated generation of phages were used for transduction of Wt Erdman Mtb 383 cultures and hyg R colonies were screened for deletion by qPCR and checking expression of 384 sulfolipid in apolar lipid fractions by TLC as per recommended protocols (51). 385
Macrophage culture and maintenance-All the cell lines used were tested for mycoplasma 386 contamination at regular intervals and cultured according to the manufacturer's 387
recommendations. THP1 cells were grown in HiglutaXL RPMI-1640 (Himedia laboratories, 388 India) with 10% FBS and differentiated by using PMA as described earlier (50). Human 389 monocyte derived macrophages (MDMs) were isolated from 20ml as described earlier (49). Forprimary mouse macrophages, bone marrow cells were harvested from the hind limbs of C57Bl6 391 mice and differentiated into macrophages in 20% L-cell supernatant for 7 days as described 392 earlier (52). 
Statistical Analysis 422
All experiments were performed in multiple biological replicates (N=2 or 3). Statistical analysis 423 was done by using Student's t-test and corresponds to a *, **, *** for p-values<0.05, <0.01and 424 <0.001, respectively. 425
Ethics Statement 426
The protocol for isolation of human 
